The BIA applauds this campaign. The chronic lack of access to capital is a challenge that unites all SMEs. These are particularly tough times for SMEs involved in crucial life sciences research, with viable enterprises still struggling to obtain the follow-on investment they need to be able to grow their businesses into the success stories of the future. Industry needs to send out a clear, united message on how to deal with this problem and get investment moving again. The package of work under discussion at the new Office for Life Sciences must be implemented to make a difference.